Company: BOLT
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0000950170-25-058632
Chunk: 55

Company: Bolt Biotherapeutics, Inc.
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 55
---
 stock options to our employees, including our named executive officers. Historically, we have granted new-hire stock option awards on or soon after a new hire’s employment start date and annual refresh employee option grants generally in the first quarter of each fiscal year. In addition, non-employee directors receive automatic grants of initial and annual stock option awards, at the time of a director’s initial appointment or election to the board of directors and at the time of each annual stockholder meeting as further described in the section titled “Director Compensation—Non-Employee Director Compensation Policy”. We have not timed the release of material non-public information for the purpose of affecting the value of executive compensation.

Incentive Compensation Recoupment Policy

We have adopted a Dodd-Frank Wall Street Reform and Consumer Protection Act-compliant compensation recoupment policy in accordance with SEC and Nasdaq requirements. Pursuant to this policy, in the event we are required to prepare an accounting restatement, we will recover any compensation received after the effective date by any current or former executive officer that is based wholly or in part upon the attainment of a financial reporting measure.

<div align='center'>35</div>

Securities Authorized for Issuance Under Equity Compensation Plans The following table shows certain information with respect to all of our equity compensation plans in effect as of December 31, 2024.

| Plan Category                 |     | Number of             
 securities to be      
 issued upon           
 exercise of           
 outstanding           
 stock options         
 and rights (column a) |            |     | Weighted-      
 average        
 exercise price 
 of outstanding 
 stock options  |      |     | Number of      
 securities     
 remaining      
 available for  
 issuance under 
 equity         
 compensation   
 plans          
 (excluding     
 securities     
 reflected      
 in column a)   |           |
|:------------------------------|:----|:----------------------|-----------:|:----|:---------------|-----:|:----|:---------------|----------:|
| Equity compensation plans     
 approved by stockholders (1)  |     |                       | 11,423,193 |     | $              | 2.50 |     |                | 2,609,694 |
| Equity compensation plans not 
 approved by stockholders      |     |                       |          — |     |                |    — |     |                |         — |
| Total                         |     |                       | 11,423,193 |     | $              | 2.50 |     |                | 2,609,694 |

(1